Live Breaking News & Updates on Inzen Therapeutics

Stay updated with breaking news from Inzen therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Adjuvant Pembrolizumab Continues to Provide Survival Benefit in Stage IIB/C Melanoma

Pembrolizumab led to sustained improvements in recurrence-free survival and distant metastasis-free vs placebo as adjuvant therapy in patients with resected stage IIB or IIC melanoma ....

Astellas-pharma , Immatics-incyte , Crown-bioscience , Jason-luke , Immunocore-incyte , Pembrolizumab-keytruda , Trex-bio , Codiak-biosciences , Bristol-myers-squibb , Serono , Novartis , Pfizer

Flagship merges two of its biotechs to form cellular microenvironment-focused Sonata

Sonata Therapeutics is developing drugs that reprogram cellular microenvironments to send signals intended to have curative effects. Cancer is the initial focus of the biotech, which Flagship Pioneering formed by combining two of its preclinical portfolio companies. ....

Cambridge , Cambridgeshire , United-kingdom , Massachusetts , United-states , Senda-biosciences , Volker-herrmann , Pearl-huang , Noubar-afeyan , Sonata-therapeutics , Flagship-pioneering-backed